Molecular mimicry: Can epitope mimicry induce autoimmune disease?

Immunology and Cell Biology

Volumn 75, Issue 2, 1997, Pages 113-126

  Davies, Janet M ^a,b  

^a MURDOCH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

altered peptide ligands; autoimmunity; cross reactivity; epitope mimicry; molecular mimicry

Indexed keywords

AUTOANTIBODY; EPITOPE; HLA ANTIGEN CLASS 1; HLA DR2 ANTIGEN; HLA DR4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANKYLOSING SPONDYLITIS; AUTOIMMUNITY; CHAGAS DISEASE; CROSS REACTION; ETIOLOGY; GUILLAIN BARRE SYNDROME; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR MIMICRY; NONHUMAN; PATHOGENESIS; REACTIVE ARTHRITIS; REVIEW; RHEUMATIC FEVER; RHEUMATOID ARTHRITIS;

EID: 0030994809     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1997.16     Document Type: Review

References (143)

1. Oldstone MBA. Molecular mimicry and autoimmune disease. Cell 1987; 50: 819-820.
2. Bulter P, Hamilton-Miller J, Baum H, Burroughs AK. Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis? Biochem. Mol. Biol. Int. 1995; 35: 473-85.
3. Luo A-M, Garza KM, Hunt D, Tung KSK. Antigen mimicry in autoimmune disease sharing of amino acid residues critical for pathogenic T cell activation. J. Clin. Invest. 1993; 92: 2117-23.
4. Neurath AR, Strick N. Antigenic mimicry of an immunoglobulin A epitope by a hepatitis B virus cell attachment site. Virology 1990; 178: 631-4.
5. Carnegie PR, Lawson MA. Viral mimicry and disease. Today's Life Sci. 1990; 2: 14-20.
6. Gao J-L, Murphy PM. Human cytomegalovirus open reading frame US28 encodes a functional β chemokine receptor. J. Biol. Chem. 1994; 269: 28 539-42.
7. Fujinami RS. Molecular Mimicry. In: Rose NR and Mackay IR (eds) The Autoimmune Diseases II. San Diego: Academic Press Inc., 1992; 153-69.
8. Smith JL, Palumbo SA, Walls I. Relationship between food-borne bacterial pathogens and the reactive arthritides. J. Food Safety 1993; 13: 209-36.
9. Silvestris F, Williams RC Jr, Dammacco F. Autoreactivity in HIV-1 infection: Role of molecular mimicry. Clin. Immunol. Immunopathol. 1995; 75: 197-205.
10. Solimena M, de Camilli P. Coxsackieviruses and diabetes. Nature Med. 1995; 1: 25-26.
11. Srinivasappa J, Saegusa J, Prabhakar BS et al. Molecular mimicry: Frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J. Virol. 1986; 57: 397-401.
12. Ray SK, Putterman C, Diamond B. Pathogenic autoantibodies are routinely generated during the response to foreign antigen: A paradigm for autoimmune disease. Proc. Natl Acad. Sci. USA 1996; 93: 2019-24.
13. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr. Opin. Immunol. 1995; 7: 812-18.
14. Allegretta M, Nicklas JA, Sriram S, Albertini RJ. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 1990; 247: 718-21.
15. Catalfamo M, Roura-Mir C, Sospedra M et al. Self-reactive cytotoxic γδ T lymphocytes in Graves' Disease specifically recognize thyroid epithelial cells. J. Immunol. 1996; 156: 804-11.
16. Bhardwaj V, Kumar V, Geysen H, Sercarz E. Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. J. Immunol. 1993; 151: 5000-10.
17. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: Viral petides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695-705.
18. Matzinger P. Tolerance, danger and the extended family. Annu. Rev. Immunol. 1994; 12: 720-41.
19. Ramsdell F, Fowlkes BJ. Clonal deletion versus clonal ancrgy: The role of the thymus in inducing self tolerance. Science 1990; 248: 1342-8.
20. Nossal GJV. Negative selection of lymphocytes. Cell 1994; 76: 229-39.
21. Vandenbark AA, Gill T, Offner H. A myelin basic protein specific T lymphocyte line which mediates experimental autoimmune encephalomyelitis. J. Immunol. 1985; 135: 22.3-8.
22. van Eden W, Hogervorst EJM, Hensen EJ, van der Zee R, van Embden JDA, Cohen IR. A cartilage-mimicking T-cell epitope on a 65 K mycobacterial heat-shock protein: Adjuvant arthritis as a model for human rheumatoid arthritis. Curr. Top. Microbiol. Immunol. 1989a; 145: 27-43.
23. Lawson CM, O'Donoghue HL, Reed WD. Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: A model for the study of molecular mimicry in the pathogensis of viral myocarditis. Immunology 1992; 75: 513-19.
24. Mamula MJ, Fatenejad S, Craft J. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J. Immunol. 1994; 152: 1453-61.
25. Fujinami RS, Oldstone MBA. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity. Science 1985; 230: 1043-5.
26. Haaheim LR, Halse A-K, Kvakestad R, Stern B, Normann O, Jonsson R. Serum antibodies from patients with primary Sjogren's syndrome and systemic lupus erythematosus recognise multiple epitopes on the La(SS-B) autoantigen resembling viral protein sequences. Scand. J. Immunol. 1996; 43: 115-21.
27. Krisher K, Cunningham MW. Myosin: A link between Streptococci and heart. Science 1985; 227: 413-15.
28. Talbot PJ, Paquette J-S, Ciurli C, Antel JP, Quellet F. Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann. Neurol. 1996; 39: 23-240.
29. Sigal LH. Molecular mimicry and Lyme Borreliosis. Ann. Neurol. 1990; 28: 195-6.
30. Schwimmbeck PL, Dyrberg T, Drachman DB, Oldstone MBA. Molecular mimicry and myasthenia gravis: An autoantigenic site of the acetylcholine receptor α-subunit that has biological activity and reacts immunologically with Herpes simplex virus. J. Climn Invest. 1989; 84: 1174-80.
31. Yamada M, Zurbriggen A, Fujinami RS. Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. J. Exp. Med. 1990; 171: 1893-907.
32. Beisel KW, Scrinivasappa J, Prabhakar BS. Identification of a putative shared epitope between coxsackie virus B4 and alpha cardiac myosin heavy chain. Clin. Exp. Immunol. 1991; 86: 49-55.
33. Gauntt CJ, Aizpe JM, Higdon AL et al. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis. J. Immunol. 1995; 154: 2983-95.
34. o protein of peripheral nerve myelin. J. Neurol. Sci. 1991; 106: 91-5.
35. Brouet J-C, Mariette X, Gendron M-C, Dubreuil M-L. Monoclonal IgM from patients with peripheral demyelinating neuropathies cross-react with bacterial polypeptides. Clin. Exp. Immunol. 1994; 96: 466-9.
36. Sabbatini A, Bombardieri S, Migliorini P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA-1. Eur. J. Immunol. 1993; 23: 1146-52.
37. 1-adrenergic receptor. J. Exp. Med. 1995; 182: 59-65.
38. van Voorhis WC, Schlekewy L, Trong HL. Molecular mimicry by Trypanosoma cruzi: The F1-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. Proc. Natl Acad. Sci. USA 1991; 88: 5993-7.
39. Grauert MR, Houdayer M, Hontebeyrie-Joskowciz M. Trypanosoma cruzi infection enhances polyreactive antibody response in an acute case of human Chagas' disease. Clin. Exp. Immunol. 1993; 93: 85-92.
40. Zwirner NW, Malchiodi EL, Chiaramonte MG, Fossati CA. A lytic monoclonal antibody to Trypanosoma cruzi blood-stream trypomastigotes which recognizes an epitope expressed in tissue affected in Chagas' disease. Infect. Immun. 1994; 62: 2483-9.
41. Van Voorhis W, Barrett L, Koelling R, Farr AG. FL-160 proteins of Trypanosoma cruzi are expressed from a multigene family and contain two distinct epitopes that mimic nervous tissues. J. Exp. Med. 1993; 178: 681-94.
42. Braun G, McKechnie NM, Gurr W. Molecular and immunological characterization of hr44, a human ocular component immunologically cross-react ice with antigen Ov39 of Onchocerca volvulus. J. Exp. Med. 1995; 182: 1121-32.
43. Donoso LA, Gregerson DS, Fling SP, Merryman C, Sery TW. The use of synthetic peptides in the study of experimental autoimmune uveitis. Curr. Eye Res. 1990; 9: 155-61.
44. Singh VK, Yamaki K, Abe T, Shinohara T. Molecular mimicry between uveitopathogenic site of retinal S-antigen and Escherichia coli protein: Induction of experimental autoimmune uveitis and lymphocyte cross-reaction. Cell. Immunol. 1989b; 122: 262-73.
45. Hartung HP, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barre syndrome-part I. Muscle Nerve 1995; 18: 147-53.
46. Hartung HP, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barre syndrome-part II. Muscle Nerve 1995; 18: 154-64.
47. Yuki N, Taki T, Imagaki F et al. A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 1993; 178: 1771-5.
48. 1 IgG antibodies and Campylobacter bacteria in Guillain-Barre syndrome: Evidence of molecular mimicry. Ann. Neurol. 1995; 38: 170-5.
49. 1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann. Neurol. 1994; 36: 791-3.
50. Myers MA, Mackay IR, Zimmet PA, Rowley MJ. Autoantibodies to glutamate decarboxylase in insulin dependent diabetes mellitus. In: Marshall S, Home P, Rizza R (eds) Diabetes Annual, Vol. 10. Amsterdam: Elsevier Science B.V., 1996; 15-36.
51. Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 1992; 89: 283-92.
52. Jones DB, Amstrong N. Proliferative lymphocyte responses to viruses containing sequence similarity to glutamic acid decarboxylase in insulin-dependent diabetes. Diabetic Med. 1994; 11 (Suppl. 2): S17.
53. Hyoty H, Hiltunen M, Knip M et al. A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 1995; 44: 652-7.
54. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J. Clin. Invest. 1994; 94: 2125-9.
55. Hou J, Said C, Franchi D, Dockstader P, Chatterjee NK. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from coxsackie virus B4 infected mice and IDDM patients. Diabetes 1994; 43: 1260-6.
56. Lohmann T, Leslie RD, Hawa M, Geysen M, Rodda S, Londei M. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet 1994; 343: 1607-8.
57. Richter W, Mertens T, Schoel B et al. Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies. J Exp. Med. 1994; 180: 721-6.
58. 65) and 2C protein of coxsackievirus B4. Clin. Exp. Immunol 1996; 104: 398-405.
59. Clements GB, Galbraith DN, Taylor KW. Coxsackie B virus infection and onset of childhood diabetes. Lancet 1995; 346: 221-3.
60. Adams DD. A theory of the pathogenesis of rheumatic fever, glomerulo-nephritis and other autoimmune disease triggered by infection. Clin. Exp. Immunol. 1969; 5: 105-15.
61. Williams RC. Rheumatic fever and the Streptococcus. Another look at molecular mimicry. Am. J. Med. 1983; 75: 727-30.
62. Dale JB, Beachy EH. Sequence of myosin-crossreactive epitopes of streptococcal M protein. J. Exp. Med. 1986; 164: 1785-90.
63. Cunningham MW, Antone SM, Gulizia JM, McManus BM, Fischetti VA, Guantt CJ. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc. Natl Acad. Sci. USA 1992; 89: 1320-4.
64. Hirota K, Kanitani H, Nemoto K, Ono T, Miyake Y. Cross-reactivity between human sialyl Lewis oligosaccharide and common causative oral bacteria of infective endocarditis. FEMS Immunol. Med. Microbiol. 1995; 12: 159-64.
65. Smiley JD, Hoffman WL. Southwestern internal medicine conference: The role of infections in the rheumatic diseases: Molecular mimicry between bacterial and human stress proteins? Am. J. Med. Sci. 1991; 301: 138-49.
66. Fielder M, Pirt SJ, Tarpey I et al. Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella pneumoniae. FEBS Lett. 1995; 369: 243-8.
67. Williams RC, Malone CC, Kao K-J. IgM rheumatoid factors react with human class I HLA molecules. J. Immunol. 1996; 156: 1684-94.
68. Haanen JBAG, Ottenhoff THM, Lai A Fat RFM, Soebono H, Spits H, de Vries RRP. Mycobacterium leprae-specific T cells from a tuberculoid leprosy patient suppress HLA-DR3-restricted T cell responses to an immunodominant epitope in 65-kDa hsp of Mycobacteria. J. Immunol. 1990; 145: 3898-904.
69. Engelhard VH. Structure of peptides associated with class I and class II MHC molecules. Annu. Rev. Immunol. 1994; 12: 181-207.
70. Chicz RM, Lane WS, Robinson RA, Rucco M, Strominger JL, Gorga JC. Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. Int. Immunol. 1994; 6: 1639-49.
71. Albani S, Roudier J. Molecular basis for the association between HLA DR4 and rheumatoid arthritis. From the shared epitope hypothesis to a peptidic model of rheumatoid arthritis. Clin. Biochem. 1992; 25: 209-12.
72. McCusker CT, Reid B, Green D, Gladman DD, Buchanan WW, Singal DP. HLA-D region antigens in patients with rheumatoid arthritis. Arthritis Rheum. 1991; 34: 192-7.
73. Albani S, Tuckwell JE, Esparza L, Carson DA, Roudier J. The susceptibility sequence to rheumatoid arthritis is a cross-reactive B cell epitope shared by the Escherichia coli heat shock protein dnaJ and the histocompatibility leukocyte antigen DRB10401 molecule. J. Clin. Invest. 1992; 89: 327-31.
74. Born W, Hall L, Dallas A et al. Recognition of a peptide antigen by heat-shock-reactive γδ T lymphocytes. Science 1990; 249: 67-9.
75. Bhar GM, Rook GAW, Al-saffar M, van Embden J, Stanford JL, Behbehani K. Antibody levels to mycobacteria in relation to HLA type: Evidence for non-HLA-linked high levels of antibody to the 65 kD heat shock protein of M. bovis in rheumatoid arthritis. Clin. Exp. Immunol. 1988; 74: 211-15.
76. Hermann E, Mayet W-J, Lohse AW, Grevenstein J, Meyer zum Buschenfelde K-H, Fleischer B. Proliferative response to synovial fluid and peripheral blood mononuclear cells to arthritogenic and non-arthritogenic microbial antigens and to the 65-kDa mycobacterial heat-shock protein. Med. Microbiol. Immunol. 1990; 179: 215-24.
77. Burmester GR, Altstidl U, Kalden JR, Emmrich F. Stimulatory response towards the 65 kDa heat shock protein and other mycobacterial antigens in patients with rheumatoid arthritis. J. Rheumatol. 1991; 18: 171-6.
78. de Graeff-Meeder ER, van der Zee R, Rijkers GT et al. Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet 1991; 337: 1368-72.
79. de Graeff-Meeder ER, Voorhorst M, van Eden W et al. Antibodies to the mycobacterial 65-kd heat-shock protein are reactive with synovial tissue of adjuvant arthritic rats and patients with rheumatoid arthritis and osteoarthritis. Am. J. Pathol. 1990; 137: 1013-17.
80. Jarjour WN, Jefferies BD, Davis JS, Welch WJ, Mimura T, Winfield JB. Autoantibodies to human stress proteins: A survey of various rheumatic and other inflammatory diseases. Arth. Rheum. 1991; 34: 1133-8.
81. Karopoulos C, Rowley MJ, Handley CJ, Strugnell RA. Antibody reactivity to mycobacterial 65 kDa heat shock protein: Relevance to autoimmunity. J. Autoimmunity, 1995; 8: 235-48.
82. Albani S, Keystone EC, Nelson JL et al. Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaj antigenic determinant in patients with early rheumatoid arthritis. Nature Med. 1995; 1: 448-52.
83. Roudier J, Petersen J, Rhodes GH, Luka J, Carson DA. Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR β-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc. Natl Acad. Sci. USA 1989; 86: 5104-8.
84. Fox RI, Luppi M, Pisa P, Kang H-I. Potential role of Epstein-Barr virus in Sjogren's syndrome and rheumatoid arthritis. J. Rheumatol. 1992; 19 (Suppl. 32): 18-24.
85. Birkenfeld P, Haratz N, Klein G, Sulitzeanu D. Cross-reactivity between the EBNA-1 p107 peptide, collagen, and keratin: Implications for the pathogenesis of rheumatoid arthritis. Clin. Immunol. Immunopathol. 1990; 54: 14-25.
86. Wilson C, Ebringer A, Ahmadi K et al. Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis. Ann. Rheum. Dis. 1995; 54: 216-20.
87. Hammer J, Gallazzi F, Bono E et al. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 1995; 181: 1847-55.
88. Golding H, Robey FA, Gates FTI et al. Identification of homologous regions in human immunodeficiency virus 1 gp41 and human MHC class II β 1 domain. J. Exp. Med. 1988; 167: 914-23.
89. Vega MA, Guigo R, Smith TF. Autoimmune response in AIDS. Nature 1990; 345: 26.
90. Zaitseva MB, Moshnikov SA, Kozhich AT et al. Antibodies to MHC class II peptides are present in HIV-1-positive sera. Scand. J. Immunol. 1992; 35: 267-73.
91. Lopalco L, De Santis C, Meneveri R et al. Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I α1 peptide binding domain. Eur. J. Immunol. 1993; 23: 2016-21.
92. Zaghouani H, Goldstein D, Shah H et al. Induction of antibodies to the envelope protein of the human immunodeficiency virus by immunization with monoclonal antiidiotypes. Proc. Natl Acad. Sci. USA 1991; 88: 5645-9.
93. Borghi MO, De Santis C, Barcellini W et al. Autoantibodies against β2-microglobulin-free HLA antigens in AIDS patients. J. Acq. Immune Def. Syndr. 1993; 6: 1114-19.
94. Rossio JL, Bess J Jr, Henderson LE, Cresswell P, Arthur LO. HLA class II on HIV particles is functional in superantigen presentation to human T cells: implications for HIV pathogenesis. AIDS Res. Hum. Retroviruses 1995; 11: 1433-9.
95. Bisset LR. Molecular mimicry in the pathogenesis of AIDS: The HIV/MHC/mycoplasma triangle. Med. Hypoth. 1994; 43: 388-96.
96. Geysen HM, Mason TJ, Rodda SJ. Cognitive features of continuous antigenic determinants. J. Mol. Recog. 1988a; 1: 32-41.
97. Tudos E, Cserzo M, Simon I. Predicting isomorphic residue replacements for protein design. Int. J. Pept. Protein Res. 1990; 36: 236-9.
98. Davies JM. Searching for molecular mimicry in lentiviral diseases of sheep and goats. PhD Thesis, Murdoch University, Western Australia, Australia, 1993.
99. Lipman DJ, Pearson WR. Rapid and sensitive protein similarity searches. Science 1985; 227: 1435-41.
100. McLachlan AD. Repeating sequences and gene duplication in proteins. J. Mol. Biol. 1972; 64: 417-37.
101. McCaldon P, Argos P. Oligopeptide biases in protein sequences and their use in predicting protein coding regions in nucleotide sequences. Proteins Struct. Funct. Genet. 1988; 4: 99-122.
102. Ohno S. To be or not to be a responder in T-cell responses: Ubiquitous oligopeptides in all proteins. Immunogenetics 1991; 34: 215-21.
103. Weise MJ, Carnegie PR. An approach to searching protein sequences for superfamily relationships or chance similarities relevant to the molecular mimicry hypothesis: Application to the basic protein of myelin. J. Neurochem. 1988; 51: 1267-73.
104. Davies JM, Sonoda S, Yashiki S, Osame M, Carnegie PR. Mimicry between HTLV-1 and myelin basic protein: No response in HTLV-1-associated myelopathy patients. J. Neuroimmunol. 1992; 41: 239-44.
105. Davies JM, Watt NJ, Torsteindottir S, Carnegie PR. Mimicry of a 21.5 kDa myelin basic protein peptide by a maedi visna virus polymerase peptide does not contribute to the pathogenesis of encephalitis in sheep. Vet. Immunol. Immunopathol. (in press).
106. Dyrberg T, Oldstone MBA. Peptides as probes to study molecular mimicry and virus-induced autoimmunity. Curr. Top. Microbiol. Immunol. 1986; 130: 25-37.
107. Quarantino S, Thorpe CJ, Travers PJ, Londei M. Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry. Proc. Natl Acad. Sci. USA 1995; 92: 10398-402.
108. Jameson B, Wolf H. The antigenic index: A novel algorithm for predicting antigenic deteminants. CABIOS 1988; 4: 181-6.
109. Delisi C, Berzofsky JA. T-cell antigenic sites tend to be amphipathic structures. Proc. Natl Acad. Sci. USA 1985; 82: 7042-52.
110. Stern PS. Predicting antigenic sites on proteins. Trends Biotechnol. 1991; 9: 163-9.
111. Hammer J. New methods to predict MHC-binding sequences within protein antigens. Curr. Opin. Immunol. 1995; 7: 263-9.
112. DiBrino M, Parker KC, Shiloach J et al. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc. Natl Acad. Sci. USA 1993; 90: 1508-12.
113. Hammer J, Belunis C, Bolin D et al. High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc. Natl Acad. Sci. USA. 1994; 91: 4456-60.
114. Wucherpfennig KW, Yu B, Bhol K et al. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: Charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc. Natl Acad. Sci. USA 1995; 92: 11 935-9.
115. Stuber G, Dillner J, Modrow S et al. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I alleles in EBNA-1. Int. Immunol. 1995; 7: 653-63.
116. Chen Y, Sidney J, Southwood S et al. Naturally processed peptides longer than nine amino acid residues bind to the class 1 MHC molecule HLA-A2.1 with high affinity and in different conformations. J. Immunol. 1994; 152: 2874-81.
117. Smilek DE, Wraith DC, Hodgkinson S, Dwivedy S, Steinman L, McDevitt HO. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl Acad Sci. USA 1991; 88: 9633-7.
118. Boehncke W-H, Takeshita T, Pendleton CD et al. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. J. Immunol. 1993; 150: 331-41.
119. Gautam AM, Pearson CI, Smilek DE, Stainman L, McDevitt HO. A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalitis. J. Exp. Med 1992; 176: 605-9.
120. Racioppi L, Ronchese F, Matis LA, Germain RN. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 1993; 177: 1047-60.
121. Sloan-Lancaster J, Allen PM. Significance of T-cell stimulation by altered peptide ligands in T cell biology. Curr. Opin. Immunol. 1995; 7: 103-9.
122. Dc Magistris MT, Alexander J, Coggeshall M et al. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 1992; 68: 625-34.
123. Dong T, Boyd D, Rosenberg W et al. An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide. Eur. J. Immunol. 1996; 26: 335-9.
124. Wauben MHM, Boog CJP, van der Zee R, Joosten I, Schlief A, van Eden W. Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: More than blocking alone. J. Exp. Med. 1992; 176: 667-77.
125. Franco A, Southwood S, Arrhenius T et al. T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis. Eur. J. Immunol. 1994; 24: 940-6.
126. Brocke S, Gijbels K, Allegretta M et al. Treatment of experimental encephalomyelitis with a peptide analgoue of myelin basic protein. Nature 1996; 379: 343-6.
127. Callahan KM, Fort MM, Obah EA, Reinherz EL, Siliciano RF. Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. J. Immunol. 1990; 144: 3341-6.
128. Klenerman P, Rowland-Jones S, McAdam S et al. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 1994; 369: 403-7.
129. Bertoletti A, Sette A, Chisari F et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994; 369: 407-10.
130. Burrows SR, Khanna R, Burrows JM, Moss DJ. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: Implications for graft-verus-host disease. J. Exp. Med. 1994; 179: 1155-61.
131. Burrows SR, Silins SL, Moss DJ, Khanna R, Misko IS, Argaet VP. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to background major histocompatibility complex antigen. J. Exp. Med. 1995; 182: 1703-15.
132. + thymocytes by T-cell receptor peptide antagonists. Proc. Natl Acad. Sci. USA 1994; 91: 4057-61.
133. Harris DP, Vordermeier H-M, Singh M, Moreno C, Jurcevic S, Ivanyi J. Cross-recognition by T cells of an epitope shared by two unrelated mycobacterial antigens. Eur. J. Immunol. 1995; 25: 3173-9.
134. Pinilla C, Chendra S, Appel JR, Houghten RA. Elucidation of monoclonal antibody polyspecificity using a synthetic combinatorial library. Pept. Res. 1995; 8: 250-7.
135. Moens U, Seternes O-M, Hey AW et al. In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones. Proc. Natl Acad. Sci. USA 1995; 92: 12 393-7.
136. Zack DJ, Yamamoto K, Wong AL, Stempniak M, French C, Weisbart RH. DNA mimics a self-protein that may be a target for some anti-DNA antibodies in synthetic lupus erythematosus. J. Immunol. 1995; 154: 1987-94.
137. Mamula MJ, Lin R-H, Janeway CJ, Hardin JA. Breaking T cell tolerance with foreign and self co-immunogens: A study of autimmune B and T cell epitopes of cytochrome c. J. Immunol. 1992; 149: 789-95.
138. James JA, Gross T, Scofield H, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunisation: Sm B/B′-derived PPPGMRPP and PPP-GIRGP induce spliceosome autoimmunity. J. Exp. Med. 1995; 181: 453-561.
139. Huang S-C, Pan Z, Kurien BT, James JA, Harley JB, Scofield, RH. Immunisation with vesicular stomatitis virus nucleocapsid protein induces autoantibodies to the 60 kD Ro ribonucleoprotein particle. J. Investig. Med. 1995; 43: 151-8.
140. Richert JR, Robinson ED, Johnson, AH et al. Heterogeneity of the T-cell receptor β gene rearrangements generated in myelin basic protein-specific T-cell clones isolated from a patient with multiple sclerosis. Ann. Neurol. 1991; 29: 299-306.
141. Bucht A, Oksenberg JR, Lindblad S, Gronberg A, Steinman L, Klareskog L. Characterization of T-cell receptor αβ repertoire in synovial tissue from different temporal phases of rheumatoid arthritis. Scand. J. Immunol. 1992a; 35: 159-65.
142. Bjorkland A, Totterman TH. Is primary biliary cirrhosis an autoimmune disease. Scand. J. Gastroenterol. 1994; 29 (Suppl. 204): 32-9.
143. Arimilli S, Mumm J, Nag B. Antigen-specific apoptosis in immortalized T cells by soluble MHC class 11-peptide complexes. Immunol. Cell Biol. 1996; 74: 96-105.